Cortagen vs Foxo4-DRI

Vascular-targeted peptide complex that modulates endothelial cell gene expression. May support nitric oxide production, reduce vascular inflammation, and improve endothelial function.

A short peptide bioregulator derived from blood vessel tissue, developed by the Khavinson Institute. Studied for cardiovascular function support and mitigation of age-related vascular deterioration.

D-retro-inverso peptide that disrupts Foxo4/p53 interaction in senescent cells; restores p53-mediated apoptosis selectively in senescent cells; clears cellular "zombie cells"

A breakthrough senolytic peptide that selectively eliminates senescent cells by restoring their ability to undergo apoptosis. Produced dramatic rejuvenation effects in preclinical studies.